Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial | Dr Aernoud Fiolet

episode

The Radcliffe Cardiology Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

NPR News: 09-18-2026 4AM EDT 5 min · 18 Sep 2026 · NPR News Now

4AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

The Lowe Job with Grace Alexander 1h 8m · 18 Sep 2026 · Barely Famous

Episode 547 | FOMO 2h 0m · 18 Sep 2026 · New Rory & MAL

Report any issue

Source

Recorded22 Apr 2022

Publisherfeeds.soundcloud.com ↗

Handlerec:4514514

Show notes

In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results. Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related